MAGEB1 and neoplasm: In contrast to benign mixed tumor cells, the level of fold change in MAGE-B1, -B4, and -B5 mRNA expression in malignant cells treated with 5-aza-CdR followed by TSA was higher than in those treated with 5-aza-CdR alone.